These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 22208480
1. Use of a keratin-based hydrogel in the management of recessive dystrophic epidermolysis bullosa. Than MP, Smith RA, Cassidy S, Kelly R, Marsh C, Maderal A, Kirsner RS. J Dermatolog Treat; 2013 Aug; 24(4):290-1. PubMed ID: 22208480 [Abstract] [Full Text] [Related]
2. Use of a keratin-based wound dressing in the management of wounds in a patient with recessive dystrophic epidermolysis bullosa. Kirsner RS, Cassidy S, Marsh C, Vivas A, Kelly RJ. Adv Skin Wound Care; 2012 Sep; 25(9):400-3. PubMed ID: 22914035 [Abstract] [Full Text] [Related]
3. Using honey to heal a chronic wound in a patient with epidermolysis bullosa. Hon J. Br J Nurs; 2012 Sep; 14(19):S4-5, S8, S10 passim. PubMed ID: 16315361 [Abstract] [Full Text] [Related]
4. Purified type I collagen wound matrix improves chronic wound healing in patients with recessive dystrophic epidermolysis bullosa. Gorell ES, Leung TH, Khuu P, Lane AT. Pediatr Dermatol; 2015 Sep; 32(2):220-5. PubMed ID: 25557742 [Abstract] [Full Text] [Related]
5. Keratin gel in the management of Epidermolysis bullosa. Denyer J, Marsh C, Kirsner RS. J Wound Care; 2015 Oct; 24(10):446-50. PubMed ID: 26488735 [Abstract] [Full Text] [Related]
6. Participatory co-design of patient-reported outcome indicators and N-of-1 evaluation of a dressing glove for Epidermolysis bullosa. Graham T, Sooriah S, Box R, Gage H, Williams P, Clemett V, Grocott P. J Wound Care; 2020 Dec 02; 29(12):751-762. PubMed ID: 33320744 [Abstract] [Full Text] [Related]
7. Evaluation of wound care options in patients with recessive dystrophic epidermolysis bullosa: a costly necessity. Kirkorian AY, Weitz NA, Tlougan B, Morel KD. Pediatr Dermatol; 2014 Dec 02; 31(1):33-7. PubMed ID: 24224977 [Abstract] [Full Text] [Related]
8. Inpatient management of children with recessive dystrophic epidermolysis bullosa: A review. Li AW, Prindaville B, Bateman ST, Gibson TE, Wiss K. Pediatr Dermatol; 2017 Nov 02; 34(6):647-655. PubMed ID: 28944966 [Abstract] [Full Text] [Related]
9. Wound closure by secondary intention is successful in the treatment of squamous cell carcinomas in recessive dystrophic epidermolysis bullosa. Rodríguez-Lojo R, Fernández-Jorge B, DE Andrés A, Peña C, García-Silva J. Eur J Dermatol; 2011 Nov 02; 21(2):302-3. PubMed ID: 21540143 [No Abstract] [Full Text] [Related]
10. Clinical trial of allogeneic cultured dermal substitute for the treatment of intractable skin ulcers in 3 patients with recessive dystrophic epidermolysis bullosa. Hasegawa T, Suga Y, Mizoguchi M, Ikeda S, Ogawa H, Kubo K, Matsui H, Kagawa S, Kuroyanagi Y. J Am Acad Dermatol; 2004 May 02; 50(5):803-4. PubMed ID: 15097978 [No Abstract] [Full Text] [Related]
11. Recessive Dystrophic Epidermolysis Bullosa and Pregnancy. Boria F, Maseda R, Martín-Cameán M, De la Calle M, de Lucas R. Actas Dermosifiliogr (Engl Ed); 2019 May 02; 110(1):50-52. PubMed ID: 29203033 [Abstract] [Full Text] [Related]
12. Wound management for children with epidermolysis bullosa. Denyer JE. Dermatol Clin; 2010 Apr 02; 28(2):257-64, viii-ix. PubMed ID: 20447488 [Abstract] [Full Text] [Related]
13. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group. Caldwell-Brown D, Stern RS, Lin AN, Carter DM. N Engl J Med; 1992 Jul 16; 327(3):163-7. PubMed ID: 1608407 [Abstract] [Full Text] [Related]
14. A case of dominant dystrophic epidermolysis bullosa with diabetes mellitus presenting as progressive recalcitrant blisters and erosions. Park K, Nakano H, Sawamura D, Kabashima K, Miyachi Y. Int Wound J; 2014 Oct 16; 11(5):567-8. PubMed ID: 23432976 [No Abstract] [Full Text] [Related]
15. [Diagnosis by electron microscopy of recessive dystrophic epidermolysis bullosa]. Glorio RR, Solari A, Woscoff A. Medicina (B Aires); 2000 Oct 16; 60(3):354-6. PubMed ID: 11050816 [Abstract] [Full Text] [Related]
16. Cutaneous verrucous xanthoma in a bone marrow transplant recipient with recessive dystrophic epidermolysis bullosa. Boyd AS, Roffwarg D. Pediatr Dermatol; 2013 Oct 16; 30(4):480-3. PubMed ID: 23600757 [Abstract] [Full Text] [Related]
17. The efficacy of trimethoprim in wound healing of patients with epidermolysis bullosa: a feasibility trial. Lara-Corrales I, Parkin PC, Stephens D, Hamilton J, Koren G, Weinstein M, Sibbald RG, Pope E. J Am Acad Dermatol; 2012 Feb 16; 66(2):264-70. PubMed ID: 22153787 [Abstract] [Full Text] [Related]
18. Study of elastase-type activity in blister fluids of recessive dystrophic epidermolysis bullosa. Francès C, Meimon G, Herson S, Robert L. Clin Physiol Biochem; 1986 Feb 16; 4(6):350-4. PubMed ID: 3643827 [Abstract] [Full Text] [Related]
19. Systemic granulocyte colony-stimulating factor (G-CSF) enhances wound healing in dystrophic epidermolysis bullosa (DEB): Results of a pilot trial. Fine JD, Manes B, Frangoul H. J Am Acad Dermatol; 2015 Jul 16; 73(1):56-61. PubMed ID: 25956659 [Abstract] [Full Text] [Related]
20. Using a dermal skin substitute in the treatment of chronic wounds secondary to recessive dystrophic epidermolysis bullosa: a case series. Sibbald RG, Zuker R, Coutts P, Coelho S, Williamson D, Queen D. Ostomy Wound Manage; 2005 Nov 16; 51(11):22-46. PubMed ID: 16319445 [Abstract] [Full Text] [Related] Page: [Next] [New Search]